Definitive Diagnostics, INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersNew York, NY
SAM.gov UEIJLUGNYE9VGS3
Definitive Diagnostics develops protein-based cancer detection technology that measures 16 protein and immune biomarkers to identify cancer-specific patterns, enhanced with artificial intelligence for pattern recognition. The company's method has been used in early testing to detect breast cancer at Stage 0 and lung, colorectal, ovarian, and pancreatic cancers at Stage I.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Definitive Diagnostics, INC | New York | NY | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.